eMedicine Specialties > Endocrinology > Pituitary Gland
Diabetes Insipidus: Follow-up
Updated: Sep 25, 2009
Follow-up
Further Inpatient Care
- Monitor for fluid retention and hyponatremia during initial therapy. Follow volume of water intake and frequency and volume of urination and inquire about thirst.
- Monitor serum sodium, 24-hour urine volumes, and specific gravity.
- Request posthospitalization follow-up visits with the patient every 6-12 months.
- Patients with normal thirst mechanisms can usually self-regulate.
Prognosis
Prognosis is excellent, depending upon underlying illness.
Patient Education
Patients must be instructed in simple principles of water balance to avoid dehydration and water intoxication (if not carefully monitoring water intake).
Miscellaneous
Medicolegal Pitfalls
The major issues are those of clarifying the diagnosis and etiology of diabetes insipidus, establishing appropriate therapy, and, most importantly, following up on a regular basis to monitor therapy.
More on Diabetes Insipidus |
| Overview: Diabetes Insipidus |
| Differential Diagnoses & Workup: Diabetes Insipidus |
| Treatment & Medication: Diabetes Insipidus |
Follow-up: Diabetes Insipidus |
| References |
| Further Reading |
| « Previous Page |
References
Earley LE, Orloff J. The mechanism of antidiuresis associated with the administration of hydrochlorothiazide to patients with vasopressin-resistant diabetes insipidus. J Clin Invest. Nov 1962;41(11):1988-97.
Kristof RA, Rother M, Neuloh G, et al. Incidence, clinical manifestations, and course of water and electrolyte metabolism disturbances following transsphenoidal pituitary adenoma surgery: a prospective observational study. J Neurosurg. Feb 6 2009;[Medline].
Seckl J, Dunger D. Postoperative diabetes insipidus. BMJ. Jan 7 1989;298(6665):2-3. [Medline].
Hadjizacharia P, Beale EO, Inaba K, et al. Acute diabetes insipidus in severe head injury: a prospective study. J Am Coll Surg. Oct 2008;207(4):477-84. [Medline].
Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol. Dec 2008;217(3):605-17. [Medline].
Hedrich CM, Zachurzok-Buczynska A, Gawlik A, et al. Autosomal dominant neurohypophyseal diabetes insipidus in two families. Molecular analysis of the vasopressin-neurophysin II gene and functional studies of three missense mutations. Horm Res. 2009;71(2):111-9. [Medline].
Richardson DW, Robinson AG. Desmopressin. Ann Intern Med. Aug 1985;ID - NIH5M01(2):228-39. [Medline].
Vande Walle J, Stockner M, Raes A, et al. Desmopressin 30 years in clinical use: a safety review. Curr Drug Saf. Sep 2007;2(3):232-8. [Medline].
Ausiello JC, Bruce JN, Freda PU. Postoperative assessment of the patient after transsphenoidal pituitary surgery. Pituitary. 2008;11(4):391-401. [Medline].
Charmandari E, Brook CG. 20 years of experience in idiopathic central diabetes insipidus [letter]. Lancet. Jun 26 1999;353(9171):2212-3. [Medline].
Czernichow P, Robinson AG. Diabetes insipidus in man. Frontiers of Hormone Research. 1985;13-24.
Pivonello R, De Bellis A, Faggiano A, et al. Central diabetes insipidus and autoimmunity: relationship between the occurrence of antibodies to arginine vasopressin-secreting cells and clinical, immunological, and radiological features in a large cohort of patients with central diabetes insipidus of known and unknown etiology. J Clin Endocrinol Metab. Apr 2003;88(4):1629-36. [Medline].
Robertson GL. Diagnosis of diabetes insipidus. Frontiers of Hormone Research. 1985;13:176-89.
Rose BD. Clinical Physiology of Acid-Base and Electrolyte Disorders. 4th ed. New York, NY:. McGraw-Hill;1994:698-720.
Further Reading
Related eMedicine topics:
Diabetes Insipidus [Pediatrics: General Medicine]
Hypernatremia [Emergency Medicine]
Hypernatremia [Nephrology]
Hypernatremia [Pediatrics: Cardiac Disease and Critical Care Medicine]
Lithium Nephropathy
Pituitary Disease and Pregnancy
Clinical guidelines:
ACR Appropriateness Criteria® neuroendocrine imaging. American College of Radiology - Medical Specialty Society. 1999 (revised 2008). 11 pages. NGC:007007
Clinical trials:
Copeptin in the Diagnosis and Differential Diagnosis of Diabetes Insipidus. The CoSIP-Study
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
Keywords
diabetes insipidus, antidiuretic hormone, ADH, DDAVP, desmopressin, vasopressin, diabetes urine, arginine vasopressin, central diabetes insipidus, nephrogenic diabetes insipidus, polyuria, polydipsia, hypernatremia, dehydration, craniopharyngioma, pineal tumors, primary intracranial tumors, idiopathic diabetes insipidus
Follow-up: Diabetes Insipidus